Breast cancer is characterized into different molecular subtypes, and each subtype is characterized by differential gene expression that are associated with distinct survival outcomes in patients. PIK3CA mutations are commonly associated with most breast cancer subtypes. More recently PIK3CA mutations have been shown to induce tumor heterogeneity and are associated with activation of EGFR-signaling and reduced relapse free survival in basal subtype of breast cancer. Thus, understanding what determines PIK3CA induced heterogeneity and oncogenesis, is an important area of investigation. In this study, we assessed the effect of mutant PIK3CA together with mutant Ras plus mutant p53 on oncogenic behavior of two distinct stem/progenitor breast cell lines, designated as K5+/K19- and K5+/K19+. Constructs were ectopically overexpressed in K5+/K19- and K5+/K19+ stem/progenitor cells, followed by various in-vitro and in-vivo analyses. Oncogene combination m-Ras/m-p53/m-PIK3CA efficiently transformed both K5+/K19- and K5+/K19+ cell lines in-vitro, as assessed by anchorage-independent soft agar colony formation assay. Significantly, while this oncogene combination induced a complete epithelial-to-mesenchymal transition (EMT) in K5+/K19- cell line, mostly epithelial phenotype with minor EMT component was seen in K5+/K19+ cell line. However, both K5+/K19- and K5+/K19+ transformed cells exhibited increased invasion and migration abilities. Analyses of CD44 and CD24 expression showed both cell lines had tumor-initiating CD44+/CD24low cell population, however transformed K5+/K19- cells had more proportion of these cells. Significantly, both cell types exhibited in-vivo tumorigenesis, and maintained their EMT and epithelial nature in-vivo in mice tumors. Notably, while both cell types exhibited increase in tumor-initiating cell population, differential EMT phenotype was observed in these cell lines. These results suggest that EMT is a cell type dependent phenomenon and does not dictate oncogenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152840 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167064 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Cross-linked graphene with chitosan nanocomposites for efficient photocatalytic degradation of bromothymol blue, bromophenol blue dye molecules.
Int J Biol Macromol
March 2025
Institute of Power Engineering, Department of Electrical Electronics, College of Engineering, Universiti Tenaga Nasional, Jalan Ikram-UNITEN, 43000 Kajang, Malaysia. Electronic address:
The pervasive occurrence of various organic contaminants, primarily dye molecules, in water bodies was caused by multiple dye industrial wastes, which recently sparked great scientific concern and public awareness due to their potential to spread these contaminants' resistant genes and pose a risk to humans. Cross-linking graphene in chitosan resulted in nanocomposites in varied morphology, increased surface area, and considerably improved photocatalytic removal of bromothymol blue and bromophenol blue. The degradation capacity of photocatalysts at various concentrations (25 and 50 mg) was 96.
View Article and Find Full Text PDFOTUB1 promotes glioma progression by stabilizing TRAF4.
Cell Signal
March 2025
Department of Neurosurgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Background: Glioma is a highly heterogeneous brain tumor with poor prognosis. This study aims to investigate the functional role of OTUB1 in glioma and its impact on TRAF4 stability, seeking potential therapeutic targets.
Methods: We mined single-cell sequencing data from 12 glioma patients to analyze the heterogeneity of 20,145 glioma cells.
Metabolic reprogramming and synergistic cytotoxicity of genistein and chemotherapy in human breast cancer cells.
Life Sci
March 2025
Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. Electronic address:
Breast cancer (BCa) is a heterogeneous disease, initially responsive to hormone therapy but often developing resistance to both hormonal and chemotherapy treatments. Novel therapeutic strategies are needed for drug-resistant BCa. Genistein, a phytoestrogen structurally similar to estrogen, competes with estrogen for receptor binding and exhibits anti-cancer effects.
View Article and Find Full Text PDFDomain alignment method based on masked variational autoencoder for predicting patient anticancer drug response.
Methods
March 2025
State University of New York, The College at Brockport, Department of Computing Sciences, 350 New Campus Drive, Brockport, NY 14422, United States. Electronic address:
Predicting the patient's response to anticancer drugs is essential in personalized treatment plans. However, due to significant distribution differences between cell line data and patient data, models trained well on cell line data may perform poorly on patient anticancer drug response predictions. Some existing methods use transfer learning strategies to implement domain feature alignment between cell lines and patient data and leverage knowledge from cell lines to predict patient anticancer drug responses.
View Article and Find Full Text PDFA hepatitis B virus-free cccDNA-producing stable cell for antiviral screening.
Antiviral Res
March 2025
Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China, 8 Huaying Road, Baiyun District, Guangzhou, Guangdong Province, 510663, China; Scientific Research Center, Shanghai Public Health Clinical Center, Shanghai, 201508, China. Electronic address:
The covalently closed circular DNA (cccDNA) of the Hepatitis B virus (HBV) serves as a template for producing progeny viruses in virally infected hepatocytes. Promising cccDNA-targeting antiviral agents remain unavailable and unpredictable in the research and development pipelines, making sterile HBV elimination challenging at the current stage. The major challenge of discriminating trace amounts of cccDNA from the abundant HBV relaxed circular DNA (rcDNA), which is nearly identical to cccDNA in sequence, substantially discourages efforts to discover and directly screen cccDNA-targeting drugs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!